Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Lethal infection by Bordetella pertussis mutants in the infant mouse model.

Weiss AA, Goodwin MS.

Infect Immun. 1989 Dec;57(12):3757-64.

2.

Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

Weiss AA, Hewlett EL, Myers GA, Falkow S.

J Infect Dis. 1984 Aug;150(2):219-22.

PMID:
6088647
3.

Genetic studies of the molecular basis of whooping cough.

Weiss AA, Hewlett EL, Myers GA, Falkow S.

Dev Biol Stand. 1985;61:11-9.

PMID:
2872097
6.

Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.

Weiss AA, Melton AR, Walker KE, Andraos-Selim C, Meidl JJ.

Infect Immun. 1989 Sep;57(9):2674-82.

7.
8.

Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.

Khelef N, Sakamoto H, Guiso N.

Microb Pathog. 1992 Mar;12(3):227-35.

PMID:
1614333
9.

Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.

Gentry-Weeks CR, Cookson BT, Goldman WE, Rimler RB, Porter SB, Curtiss R 3rd.

Infect Immun. 1988 Jul;56(7):1698-707.

11.

Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Weiss AA, Hewlett EL, Myers GA, Falkow S.

Infect Immun. 1983 Oct;42(1):33-41.

12.

Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

Gueirard P, Guiso N.

Infect Immun. 1993 Oct;61(10):4072-8.

13.

Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin.

Khelef N, Guiso N.

FEMS Microbiol Lett. 1995 Dec 1;134(1):27-32.

PMID:
8593951
14.

Molecular aspects of Bordetella pertussis pathogenesis.

Locht C.

Int Microbiol. 1999 Sep;2(3):137-44. Review.

PMID:
10943406
15.

Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Khelef N, Danve B, Quentin-Millet MJ, Guiso N.

Infect Immun. 1993 Feb;61(2):486-90.

16.

Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Finn TM, Shahin R, Mekalanos JJ.

Infect Immun. 1991 Sep;59(9):3273-9.

17.

Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.

Khelef N, Bachelet CM, Vargaftig BB, Guiso N.

Infect Immun. 1994 Jul;62(7):2893-900. Erratum in: Infect Immun 1994 Dec;62(12):5707.

18.
19.

Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.

Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P.

Infect Immun. 2017 May 23;85(6). pii: e00937-16. doi: 10.1128/IAI.00937-16. Print 2017 Jun.

20.

Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.

Arciniega JL, Hewlett EL, Edwards KM, Burns DL.

FEMS Immunol Med Microbiol. 1993 Apr;6(4):325-30.

PMID:
8499896

Supplemental Content

Support Center